TipRanks
Consun Pharmaceutical Group Ltd. (DE:C1P)
FRANKFURT:C1P
Germany Market
C1P
Consun Pharmaceutical Group Ltd.
RESEARCH TOOLSreports

Consun Pharmaceutical Group Ltd. (C1P) Income Statement

2 Followers

Consun Pharmaceutical Group Ltd. Income Statement

Last quarter (Q2 2026), Consun Pharmaceutical Group Ltd.'s total revenue was ¥1.76B, an increase of 38.75% from the same quarter last year. In Q2, Consun Pharmaceutical Group Ltd.'s net income was ¥587.09M. See Consun Pharmaceutical Group Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 3.42B¥ 2.97B¥ 2.59B¥ 2.34B¥ 2.04B
Gross Profit
¥ 2.67B¥ 2.24B¥ 1.92B¥ 1.76B¥ 1.53B
Operating Expenses
¥ 1.46B¥ 1.20B¥ 1.04B¥ 1.01B¥ 818.57M
Depreciation and Amortization
¥ 55.61M¥ 71.58M¥ 78.09M¥ 70.48M¥ 68.53M
EBITDA
¥ 1.21B¥ 1.05B¥ 963.06M¥ 785.89M¥ 728.71M
Operating Income
¥ 1.20B¥ 1.05B¥ 884.97M¥ 757.33M¥ 708.77M
Other Income/Expenses
¥ -5.96M¥ -24.95M¥ -21.26M¥ -10.93M¥ -12.90M
Pretax Income
¥ 1.20B¥ 1.02B¥ 863.70M¥ 746.39M¥ 695.86M
Net Income
¥ 1.08B¥ 910.46M¥ 784.53M¥ 682.91M¥ 590.17M
Per Share Metrics
Basic EPS
¥ 1.26¥ 1.11¥ 0.98¥ 0.86¥ 0.74
Diluted EPS
¥ 1.26¥ 1.09¥ 0.98¥ 0.86¥ 0.73
Weighted Average Shares Outstanding
 855.13M 821.10M 799.17M 790.63M 801.58M
Weighted Average Shares Outstanding (Diluted)
 855.13M 832.11M 799.17M 792.00M 804.70M
Currency in CNY

Consun Pharmaceutical Group Ltd. Earnings and Revenue History